TY  - JOUR
AU  - Cordoba-Chacon, Jose
AU  - Sarmento-Cabral, Andre
AU  - Del Rio-Moreno, Mercedes
AU  - Diaz-Ruiz, Alberto
AU  - Subbaiah, Papasani V
AU  - Kineman, Rhonda D
PY  - 2018
DO  - 10.1210/en.2018-00669
UR  - http://hdl.handle.net/10668/13040
T2  - Endocrinology
AB  - Nonalcoholic fatty liver disease (NAFLD), which includes nonalcoholic steatohepatitis (NASH), is associated with reduced GH input/signaling, and GH therapy is effective in the reduction/resolution of NAFLD/NASH in selected patient populations. Our...
LA  - en
PB  - Oxford University Press
KW  - Adipose tissue, white
KW  - Alanine transaminase
KW  - Animals
KW  - Disease models, animal
KW  - Gene knockdown techniques
KW  - Growth hormone
KW  - Hepatocytes
KW  - Lipid metabolism
KW  - Lipogenesis
KW  - Lipolysis
KW  - Liver
KW  - Liver cirrhosis
KW  - Male
KW  - Mice
KW  - Non-alcoholic fatty liver disease
KW  - Receptors, somatotropin
TI  - Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction.
TY  - Research article
VL  - 159
ER  -